|
1
|
Li J and Lee AS: Stress induction of
GRP78/BiP and its role in cancer. Curr Mol Med. 6:45–54. 2006.
|
|
2
|
Srivastava PK: Therapeutic cancer
vaccines. Curr Opin Immunol. 18:201–205. 2006.
|
|
3
|
Fu Z, Deng H, Wang X, et al: Involvement
of ER-alpha36 in the malignant growth of gastric carcinoma cells is
associated with GRP94 overexpression. Histopathology. 63:325–333.
2013.
|
|
4
|
Sheu ML, Liu SH and Lan KH: Honokiol
induces calpain-mediated glucose-regulated protein-94 cleavage and
apoptosis in human gastric cancer cells and reduces tumor growth.
PLoS One. 2:e10962007.
|
|
5
|
Lambert R, Guilloux A, Oshima A, et al:
Incidence and mortality from stomach cancer in Japan, Slovenia and
the USA. Int J Cancer. 97:811–818. 2002.
|
|
6
|
Brenner H, Rothenbacher D and Arndt V:
Epidemiology of stomach cancer. Methods Mol Biol. 472:467–477.
2009.
|
|
7
|
Chandanos E, Lindblad M, Rubio CA, et al:
Tamoxifen exposure in relation to gastric adenocarcinoma
development. Eur J Cancer. 44:1007–1014. 2008.
|
|
8
|
Rutqvist LE, Johansson H, Signomklao T, et
al: Adjuvant tamoxifen therapy for early stage breast cancer and
second primary malignancies. Stockholm Breast Cancer Study Group. J
Natl Cancer Inst. 87:645–651. 1995.
|
|
9
|
Deng H, Huang X, Fan J, et al: A variant
of estrogen receptor-alpha, ER-alpha36 is expressed in human
gastric cancer and is highly correlated with lymph node metastasis.
Oncol Rep. 24:171–176. 2010.
|
|
10
|
Wang X, Deng H, Zou F, et al:
ER-alpha36-mediated gastric cancer cell proliferation via the c-Src
pathway. Oncol Lett. 6:329–335. 2013.
|
|
11
|
Wang Z, Zhang X, Shen P, et al: A variant
of estrogen receptor-α, hER-α36: transduction of estrogen- and
antiestrogen-dependent membrane-initiated mitogenic signaling. Proc
Natl Acad Sci USA. 103:9063–9068. 2006.
|
|
12
|
Fu ZQ, Yang Y, Song J, et al: LiCl
attenuates thapsigargin-induced tau hyperphosphorylation by
inhibiting GSK-3beta in vivo and in vitro. J Alzheimers Dis.
21:1107–1117. 2010.
|
|
13
|
Deng H, Zhen H, Fu Z, et al: The
antagonistic effect between STAT1 and Survivin and its clinical
significance in gastric cancer. Oncol Lett. 3:193–199. 2012.
|
|
14
|
Kang L, Zhang X, Xie Y, et al: Involvement
of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic
estrogen signaling. Mol Endocrinol. 24:709–721. 2010.
|
|
15
|
Suntharalingam A, Abisambra JF, O’Leary JC
III, et al: Glucose-regulated protein 94 triage of mutant myocilin
through endoplasmic reticulum-associated degradation subverts a
more efficient autophagic clearance mechanism. J Biol Chem.
287:40661–40669. 2012.
|
|
16
|
Zheng HC, Takahashi H, Li XH, et al:
Overexpression of GRP78 and GRP94 are markers for aggressive
behavior and poor prognosis in gastric carcinomas. Hum Pathol.
39:1042–1049. 2008.
|
|
17
|
Jones PF, Jakubowicz T, Pitossi FJ, Maurer
F and Hemmings BA: Molecular cloning and identification of a
serine/threonine protein kinase of the second-messenger subfamily.
Proc Natl Acad Sci USA. 88:4171–4175. 1991.
|
|
18
|
Garcia GE, Nicole A, Bhaskaran S, et al:
Akt-and CREB-mediated prostate cancer cell proliferation inhibition
by Nexrutine, a Phellodendron amurense extract. Neoplasia.
8:523–533. 2006.
|
|
19
|
Gottlob K, Majewski N, Kennedy S, et al:
Inhibition of early apoptotic events by Akt/PKB is dependent on the
first committed step of glycolysis and mitochondrial hexokinase.
Genes Dev. 15:1406–1418. 2001.
|
|
20
|
Ang KL, Shi DL, Keong WW and Epstein RJ:
Upregulated Akt signaling adjacent to gastric cancers: implications
for screening and chemoprevention. Cancer Lett. 225:53–59.
2005.
|
|
21
|
Oki E, Baba H, Tokunaga E, et al: Akt
phosphorylation associates with LOH of PTEN and leads to
chemoresistance for gastric cancer. Int J Cancer. 117:376–380.
2005.
|
|
22
|
Yu HG, Ai YW, Yu LL, et al:
Phosphoinositide 3-kinase/Akt pathway plays an important role in
chemoresistance of gastric cancer cells against etoposide and
doxorubicin induced cell death. Int J Cancer. 122:433–443.
2008.
|
|
23
|
Guo RX, Wei LH, Tu Z, et al: 17
beta-estradiol activates PI3K/Akt signaling pathway by estrogen
receptor (ER)-dependent and ER-independent mechanisms in
endometrial cancer cells. J Steroid Biochem Mol Biol. 99:9–18.
2006.
|
|
24
|
Stoica GE, Franke TF, Wellstein A, et al:
Estradiol rapidly activates Akt via the ErbB2 signaling pathway.
Mol Endocrinol. 17:818–830. 2003.
|
|
25
|
Park S, Song J, Joe CO and Shin I: Akt
stabilizes estrogen receptor alpha with the concomitant reduction
in its transcriptional activity. Cell Signal. 20:1368–1374.
2008.
|
